Do matrix metalloproteinases MMP-2 and MMP-9 (gelatinases) play a role in renal development, physiology and glomerular diseases?

Current Opinion in Nephrology and Hypertension

Volumn 10, Issue 1, 2001, Pages 7-12

  Lelongt, Brigitte ^a   Legallicier, Bruno ^a   Piedagnel, Rémi ^a   Ronco, Pierre M ^a,b  

^a INSERM   (France)

^b HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B;

ANIMAL MODEL; ANIMAL TISSUE; CELL INVASION; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ANALYSIS; GLOMERULOPATHY; KIDNEY DEVELOPMENT; MOUSE; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; EMBRYONIC AND FETAL DEVELOPMENT; KIDNEY; KIDNEY DISEASES; KIDNEY GLOMERULUS; KIDNEY TUBULES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9;

EID: 0035136101     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200101000-00002     Document Type: Review

References (43)

1. Regulation of matrix metalloproteinase expression in tumor invasion
2. Matrix metalloproteinases in renal development and disease
3. Structure regulation and function
4. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis
5. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system
6. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions
7. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinase-1
8. Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros
9. Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitro
10. Cloning of murine membrane-type-1-matrix metalloproteinase (MT-1-MMP) and its metanephric developmental regulation with respect to MMP-2 and its inhibitor
11. Role of membrane-type matrix metalloproteinase 1 (MT-1-MMP), MMP-2, and its inhibitor in nephrogenesis
12. Inductive interactions between the mesenchyme and the ureteric bud
13. Basement membrane in develoment
14. Molecular cloning of murine 72-kDa type IV collagenase and its expression during mouse development
15. Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis
16. Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice
17. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes
18. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions
19. Gelatinase B (MMP-9) is not essential in the normal kidney and does not influence progression of renal disease in a mouse model of Alport syndrome
20. 92-kDa type IV collagenase and TIMP3, but not 72-kDa type IV collagenase or TIMP-1 or TIMP-2, are highly expressed during mouse embryo implantation
21. Expression and function of matrix metalIoproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation
22. High expression of the 92-kDa type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development
23. Matrix metalloproteinase 2 (MMP2) and MMP9 are produced by kidney collecting duct principal cells but are differentially regulated by SV40 large-T, arginine vasopressin, and epidermal growth factor
24. Matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases expression by tubular epithelia and interstitial fibroblasts in the normal kidney and in fibrosis
25. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins
26. Neutral proteinase activity produced in vitro by cells of the glomerular mesangium
27. Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy
28. The purification and characterization of a glomerular-basement-membrane-degrading neutral proteinase from rat mesangial cells
29. Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin dependent diabetes mellitus
30. Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation
31. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5
32. Matrix metalloproteinase deficiencies affect contact hypersensitivity: Stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response
33. Degradation of interleukin-1 beta by matrix metalloproteinases
34. Matrix metalloproteinases as insulin-like growth factor binding protein-degrading proteinases
35. Inhibition of matrix metalloproteinases attenuates anti-Thy 1.1 nephritis
36. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid
37. Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin dependent diabetes mellitus
38. Plasma matrix metalloproteinase-9 and diabetic microalbuminuria: Tip of the iceberg
39. Urine activity of cathepsin B, collagenase and urine excretion of TGF-beta 1 and fibronectin in membranous glomerulonephritis
40. Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis
41. Molecular and functional defects in kidney of mice lacking collagen α3 (IV): Implications for Alport syndrome
42. Interstitial fibrosis in mice with overload proteinuria: Deficiency of TIMP-1 is not protective
43. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction